top of page
The Thesis
1850S TO 1950S
Public Health
Population-scale intervention through civic infrastructure: sanitation, vaccines, maternity care. A new layer of health value, built from scratch.
1950S TO 2020S
Hospital Health
Clinician-led systems focused on specialisation and treatment. Hospitals, pharmaceuticals, modern medicine. Enormous capital deployed. Enormous returns generated.
2020S ONWARDS
Personalised Health
Distributed, data-driven, patient-enabled care. Prevention, prediction, personalised treatment pathways. The transition is underway. The infrastructure companies are being built now.
120+
£320m+
Years of combined healthcare experience across the partnership
Capital raised across partner ventures
$20bn+
32 countries
Combined exit value across prior Partner funds and backed
companies.
Global network and market reach
What we back
We back the technologies, platforms and infrastructure shaping the future of healthcare.
AI Diagnostics
Improving diagnosis, detection and clinical decision-making at scale.
Health Data Platforms
Connecting systems, workflows and healthcare data across care settings.
Genomics
Precision medicine, prevention and personalised treatment pathways.
Medical Devices
Technologies enabling modern healthcare delivery outside hospital settings.
Workflow Automation
Improving efficiency, capacity and clinical operations for health systems.
Clinical Infrastructure
The underlying systems and platforms supporting healthcare at scale.
Work with Havilland Active Ventures
We run dedicated pathways for founders and investors to ensure enquiries reach the right team.
For founders
Building a healthcare company at Series A or B? Tell us about your company.
For investors
Interested in Havilland Active Ventures Fund I? We are in first close and welcoming LP conversations.
bottom of page